Tripartite Therapeutics Inc. (TPEX:7920)

Market Cap	4.71B
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	593.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,279,573
Open	7.97
Previous Close	8.14
Day's Range	7.72 - 8.29
52-Week Range	5.91 - 20.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Tripartite Therapeutics

Tripartite Therapeutics Inc. engages in the development of proprietary platform technologies for targeted delivery of therapeutics in Taiwan. Its proprietary OmniLink technology, helps in the therapeutic potential of active pharmaceutical ingredients that were previously limited by toxicities, in vivo stabilities, and unfavorable pharmacokinetic profiles. The company aims to generate a pipeline of treatments for cancer tumors, unmet medical needs in oncology, metabolic diseases, vaccines, and other disease indications. The company was founded i...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7920

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 18, 2026

Data Sources Report a data error